Compare WSBF & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WSBF | CMPS |
|---|---|---|
| Founded | 1921 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 336.7M | 1.2B |
| IPO Year | 2013 | 2020 |
| Metric | WSBF | CMPS |
|---|---|---|
| Price | $18.70 | $12.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $25.38 |
| AVG Volume (30 Days) | 44.9K | ★ 3.7M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | ★ 46.53 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $54.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.71 | $2.25 |
| 52 Week High | $18.88 | $12.48 |
| Indicator | WSBF | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 70.58 |
| Support Level | $17.69 | $4.66 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.38 | 0.81 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 93.97 | 96.26 |
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.